O

Octave Bioscience

77 employees

Octave is a biotechnology company that uses precision medicine and scientific insights to treat patients with multiple sclerosis.

Basic info

Industry

biotechnology research

Sectors

Biotechnology
neurodegenerative disease
blood biomarker
proteomics
multiple sclerosis
AI
precision care
machine learning
Clinical Trials
care management
patient monitoring
neuroimaging
analytics
Health Diagnostics
Health Care
data science
Medical

Date founded

2014

Funding rounds raised

Total raised

$32M

from 13 investors over 13 rounds

O

Octave Bioscience raised $30M on July 26, 2023

Investors: Section 32, Northpond Ventures, Hikma Ventures, Casdin Capital, LLC, Intermountain Ventures and ECHO

O

Octave Bioscience raised $32M on December 17, 2020

Investors: ECHO, Northpond Ventures, Section 32 and Casdin Capital, LLC

O

Octave Bioscience raised $14M on July 12, 2018

Investors: ECHO, The Blue Venture Fund and Section 32

FAQ